Curative Biosciences, Inc. (CBDX) es una empresa que cotiza en bolsa en el Salud sector, operando dentro de la Drug Manufacturers - Specialty & Generic industria. La empresa tiene su sede en Miami, FL, United States. El CEO actual es Katherine T. Alverson West.
CBDX tiene fecha de IPO 2004-08-26, cotiza en el Other OTC, una capitalización de mercado de $25.79K.
Curative Biosciences, Inc. focuses on developing and commercializing therapeutics using hemp-derived Cannabidiol. It intends to manufacture and market natural health products and operate in the medical cannabis industry. The company was formerly known as Amaize Beverage Corporation and changed its name to Curative Biosciences, Inc. in August 2017. Curative Biosciences, Inc. was founded in 2009 and is based in Miami, Florida.
